Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.